Back
Relmada Therapeutics, Inc. RLMD · Transcripts
website
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. ...17
Price3.9
Market Cap416.01 M
Float82.64 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents